Alteplase for Acute Ischemic Stroke in Patients Aged >80 Years

Pooled analyses of individual patient data from 7 RCTs of alteplase (n=6035) and registry studies support a positive benefit–risk profile of alteplase for acute ischaemic stroke, in patients aged >80 years, when administered according to other European regulatory criteria.

Source:

Stroke